Annita Montepeloso, PhD, is a senior researcher with over 10 years of experience in the field of hematopoietic stem and progenitor cell (HSPC) gene therapy for neurodegenerative and neurometabolic diseases.  She developed her carrier working at the San Raffaele Telethon Institute for Gene Therapy in Milano between 2013 and 2015, and from 2015 to 2022 at the Gene Therapy Program, Dana Farber/Boston Children’s Hospital, Harvard Medical School in Boston, MA.

Her research contributed to the development of innovative strategies for the treatment of neurodegenerative and neurometabolic diseases and in the development of preclinical and clinical protocol for advanced gene therapy applications based on HSPC.

Her work is published in peer-reviewed journals in the field of cell and gene therapy.

No Comments

Sorry, the comment form is closed at this time.